A Two-part, Crossover Study to Investigate the Effects of Morning Versus Evening Dosing and Food Interaction on the Pharmacodynamics and Pharmacokinetics of Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women.

Trial Profile

A Two-part, Crossover Study to Investigate the Effects of Morning Versus Evening Dosing and Food Interaction on the Pharmacodynamics and Pharmacokinetics of Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 Jan 2016

At a glance

  • Drugs ONO 5334 (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Adverse reactions; Biomarker; Pharmacodynamics; Pharmacokinetics
  • Sponsors Ono Pharmaceutical
  • Most Recent Events

    • 16 Oct 2012 Results comparing effects of morning versus evening administration on bone turnover markers presented at the 34th Annual Meeting of the American Society for Bone and Mineral Research.
    • 24 Jul 2012 Actual end date (1 Dec 2011) added as reported by ClinicalTrials.gov.
    • 28 Jun 2011 Planned end date (1 Nov 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top